• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
In the last 6 hours
Earlier today
Yesterday
In the last 7 days
Monthly IV version of Leqembi set for FDA review by next year Pharmaceutical Technology11:57 10-Jun-24
In the last month
Oligonucleotide ALS therapy approved in EU European Pharmaceutical Review11:08 31-May-24
Biogen Acquires Human Immunology Bioscience European Pharmaceutical Manufacturer03:22 24-May-24
Biogen may tap RCF International Financing Review01:11 24-May-24
Biogen enters deal to acquire HI-Bio for $1.8bn Pharmaceutical Technology06:05 23-May-24
FDA Approves First Biosimilars to Eylea Pharmacy Times17:24 20-May-24
view more headlines
12 Jun 11:51

About our Biogen News

Biogen is an American multinational biotechnology company that specialises in treatment of neurological diseases.


Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.